03/24/2025
3:12 PM | Immuneering (Issuer)
Matushansky Igor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:47 PM | Immuneering (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2025
3:07 PM | Immuneering (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
3:06 PM | Bookman Michael (Reporting)
Immuneering (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:10 PM | Immuneering (Issuer)
Zeskind Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:36 PM | Immuneering (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
7:26 AM | Immuneering (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:12 PM | Feinberg Peter (Reporting)
Immuneering (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:19 PM | BERMAN ANN E (Reporting)
Immuneering (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:06 PM | Immuneering (Issuer)
KEATING LAURIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
2:03 PM | Cormorant Asset Management, LP (Filed by)
Immuneering (Subject)
| Form SC 13G/A | |
Get the Latest News and Ratings for IMRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Immuneering and its competitors with MarketBeat's FREE daily newsletter. |
09/12/2024
3:11 PM | Immuneering (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
3:09 PM | Immuneering (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
3:14 PM | Immuneering (Issuer)
Immuneering (Issuer)
Neufeld Leah R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:15 PM | Brakewood Harold Eugene (Reporting)
Immuneering (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:18 PM | Immuneering (Issuer)
Morales Mallory (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:20 PM | Bookman Michael (Reporting)
Immuneering (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:09 PM | Immuneering (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2024
3:17 PM | Immuneering (Filer)
| Form DEFA14A | |
04/23/2024
3:12 PM | Immuneering (Filer)
| Form DEF 14A | |
04/15/2024
5:10 PM | Cormorant Asset Management, LP (Filed by)
Immuneering (Subject)
| Form SC 13G/A | |
04/10/2024
11:58 AM | Immuneering (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
Immuneering (Subject)
| Form SC 13G/A | |
04/03/2024
4:37 PM | Chen Bihua (Reporting)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Cormorant Private Healthcare Fund III LP (Reporting)
Immuneering (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
12:12 PM | Immuneering (Subject)
Merrin Investors LLC (Filed by)
| Form SC 13G/A | |
Buy IMRX Stock Free IMRX Stock Alerts